BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21968648)

  • 1. Expression of Y-Box-binding protein 1 in Chinese patients with breast cancer.
    Xie W; Yang J; Cao Y; Peng C; Ning H; Zhang F; You J
    Tumour Biol; 2012 Feb; 33(1):63-71. PubMed ID: 21968648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of cytoplasmic Y-box-binding protein 1 as a prognostic marker for breast cancer in Korean.
    Lee A; Woo J; Park H; Sung SH; Seoh JY; Lim W; Moon BI
    Breast Cancer; 2016 Sep; 23(5):685-91. PubMed ID: 26193840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
    Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.
    Dahl E; En-Nia A; Wiesmann F; Krings R; Djudjaj S; Breuer E; Fuchs T; Wild PJ; Hartmann A; Dunn SE; Mertens PR
    BMC Cancer; 2009 Nov; 9():410. PubMed ID: 19930682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
    Nishio S; Ushijima K; Yamaguchi T; Sasajima Y; Tsuda H; Kasamatsu T; Kage M; Ono M; Kuwano M; Kamura T
    Gynecol Oncol; 2014 Mar; 132(3):703-8. PubMed ID: 24486603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.
    Shiraiwa S; Kinugasa T; Kawahara A; Mizobe T; Ohchi T; Yuge K; Fujino S; Katagiri M; Shimomura S; Tajiri K; Sudo T; Kage M; Kuwano M; Akagi Y
    Anticancer Res; 2016 Jul; 36(7):3781-8. PubMed ID: 27354655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of sex-determining region Y-box 30 with tumor characteristics and its prognostic value in breast cancer.
    Peng H; Luo Y; Wu J; Yin W
    J Clin Lab Anal; 2020 Jun; 34(6):e23232. PubMed ID: 32157740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China.
    Wei JT; Huang WH; Du CW; Qiu SQ; Wei XL; Liu J; Zhang GJ
    Sci Rep; 2014 Jun; 4():5360. PubMed ID: 24942640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression level and prognostic value of Y-box binding protein-1 in rectal cancer.
    Zhang Y; Zhao PW; Feng G; Xie G; Wang AQ; Yang YH; Wang D; Du XB
    PLoS One; 2015; 10(3):e0119385. PubMed ID: 25790262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-box transcription factor 21 expression in breast cancer and its relationship with prognosis.
    Yu H; Yang J; Jiao S; Li Y; Zhang W; Wang J
    Int J Clin Exp Pathol; 2014; 7(10):6906-13. PubMed ID: 25400774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
    Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
    Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
    Mirza S; Rakha EA; Alshareeda A; Mohibi S; Zhao X; Katafiasz BJ; Wang J; Gurumurthy CB; Bele A; Ellis IO; Green AR; Band H; Band V
    Breast Cancer Res Treat; 2013 Feb; 137(3):721-31. PubMed ID: 23288344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of YB-1 protein in breast tumors].
    Gens GP; Stromskaia TP; Kalita OV; Vaĭman AV; Rybalkina EIu; Ovchinnikov LP; Sorokin AV; Korobkova LI; Astrakhantsev AF; Mukha SF; Moiseeva NI; Stavrovskaia AA
    Klin Lab Diagn; 2009 Apr; (4):21-4. PubMed ID: 19517610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of TβRII Expression in Breast Cancer.
    Gao N; Zhai Q; Li Y; Huang K; Bian D; Wang X; Liu C; Xu H; Zhang T
    PLoS One; 2015; 10(11):e0141412. PubMed ID: 26551005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.